Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 921

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Clinical Features of COVID-19-Related Liver Functional Abnormality

Open access
Fan, Zhenyu, Chen, Liping, Li, Jun, Cheng, Xin, Yang, Jingmao, Tian, Cheng, Zhang, Yajun, Huang, Shaoping, Liu, Zhanju, Cheng, Jilin·2020·Clinical Gastroenterology and Hepatology

Published version of a preprint

Abstract

Background & Aims Some patients with SARS-CoV-2 infection have abnormal liver function. We aimed to clarify the features of COVID-19-related liver damage to provide references for clinical treatment. Methods We performed a retrospective, single-center study of 148 consecutive patients with confirmed COVID-19 (73 female, 75 male; mean age, 50 years) at the Shanghai Public Health Clinical Center from January 20 through January 31, 2020. Patient outcomes were followed until February 19, 2020. Patients were analyzed for clinical features, laboratory parameters (including liver function tests), medications, and length of hospital stay. Abnormal liver function was defined as increased levels of alanine and aspartate aminotransferase, gamma glutamyltransferase, alkaline phosphatase, and total bilirubin. Results Fifty-five patients (37.2%) had abnormal liver function at hospital admission; 14.5% of these patients had high fever (14.5%), compared with 4.3% of patients with normal liver function (P = .027). Patients with abnormal liver function were more likely to be male, and had higher levels of procalcitonin and C-reactive protein. There was no statistical difference between groups in medications taken before hospitalization; a significantly higher proportion of patients with abnormal liver function (57.8%) had received lopinavir/ritonavir after admission compared to patients with normal liver function (31.3%). Patients with abnormal liver function had longer mean hospital stays (15.09 ± 4.79 days) than patients with normal liver function (12.76 ± 4.14 days) (P = .021). Conclusions More than one third of patients admitted to the hospital with SARS-CoV-2 infection have abnormal liver function, and this is associated with longer hospital stay. A significantly higher proportion of patients with abnormal liver function had received lopinavir/ritonavir after admission; these drugs should be given with caution.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cgh.2020.04.002

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 29 references

Research works printed but not linked: 2

  1. Yancheva, 2019, A case of late presentation of darunavir-related cholestatic hepatitis, Int J STD AIDS, 30, 620, 10.1177/0956462419826723 · doi:10.1177/0956462419826723
  2. Chen, 2020, Efficacies of lopinavir/ritonavir and arbidol in the treatment of novel coronavirus pneumonia, Chin J Infect Dis, 38, 86

Cited by

See all 921

Metadata

Authors
Fan, Z., Chen, L., Li, J., Cheng, X., Yang, J., Tian, C., Zhang, Y., Huang, S., Liu, Z., & Cheng, J.
Venue
Clinical Gastroenterology and Hepatology
Publisher
Elsevier BV
Published
2020-06
Volume
18
Issue
7
Pages
1561-1566
ISSN
1542-3565 (ISSN-L)
OpenAlex
W3015256585
Cited by
921
References
29
FWCI
25.23
Type
journal article
Language
en
Open access
green
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
  • National Major Science and Technology Projects of China
  • Science and Technology Commission of Shanghai Municipality

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical Features of COVID-19-Related Liver Functional Abnormality. https://app.cochat.ai/papers/10.1016/j.cgh.2020.04.002
The paper
Fan, Z., Chen, L., Li, J., Cheng, X., Yang, J., Tian, C., Zhang, Y., Huang, S., Liu, Z., & Cheng, J. (2020). Clinical Features of COVID-19-Related Liver Functional Abnormality. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2020.04.002

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.